Evolving patient needs and market complexities are reshaping how support models are built and measured. This whitepaper offers insights and real-world strategies to help pharmaceutical teams adapt, optimize programs, and improve outcomes.

Avoid costly missteps with our proven solutions, backed by over 45 years of experience. You'll gain access to our worldwide distribution network, global expertise, and intimate understanding of local markets. We tailor every strategy to your product for faster speeds to market & greater confidence.

Since launching the first FDA-approved companion diagnostic 25 years ago, Agilent continues to deliver CDx solutions in close collaboration with our pharma partners worldwide. Our broad technical expertise, global infrastructure and decades of commercial experience make us a proven CDx partner.

Meet us at ASCO in Booth 36076 to discuss your CDx needs. 

Our latest whitepaper shows how researchers are exploring the effectiveness of combining antibody drug conjugates and immune checkpoint inhibitors in non-small cell lung cancer. Download now.